THE OVARIAN RESERVE IN PATIENTS WITH HEMORRHAGIC OVARIAN APOPLEXY AFTER SURGICAL TREATMENT


Citar

Texto integral

Acesso aberto Acesso aberto
Acesso é fechado Acesso está concedido
Acesso é fechado Acesso é pago ou somente para assinantes

Resumo

Objective. To comparatively study the impact of different methods of surgical hemostasis on ovarian reserve in patients with hemorrhagic ovarian apoplexy on the basis of a series of investigations of anti-Müllerian hormone and calculations of the number of antral follicles. Subject and methods. Forty-seven patients with hemorrhagic ovarian apoplexy who had undergone electric surgical bipolar and suture hemostasis. A control group was composed of 25 patients with painful ovarian apoplexy confirmed by laparoscopy. All the patients were divided into age groups. Results. All the age groups showed reductions in the levels of anti-Müllerian hormone and the number of antral follicles. The bipolar hemostasis group displayed a statistically significant decrease in the indicators under study. Conclusion. Bipolar coagulation gives rise to a greater ovarian reserve loss than suture hemostasis and is characterized by a higher decline in an ovarian response and conception rates.

Texto integral

Acesso é fechado

Sobre autores

O. OVLASHENKO

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: eovlashenko@mail.ru
Department of Reproductive Medicine and Surgery, Faculty of Postgraduate Training

S. KISELEV

A.I. Evdokimov Moscow State University of Medicine and Dentistry

Email: s.i.kiselev@mail.ru
Department of Reproductive Medicine and Surgery, Faculty of Postgraduate Training

E. YAROTSKAYA

A.I. Evdokimov Moscow State University of Medicine and Dentistry; Academician V. I. Kulakov Research Center of Obstetrics, Gynecology, and Perinatology, Ministry of Health of the Russian Federation

Email: inter_otdel@mail.ru
Department of Reproductive Medicine and Surgery, Faculty of Postgraduate Training

M. TSIKARISHVILI

O.M. Filatov City Clinical Hospital Fifteen

Email: info@gkb15.mosgorzdrav.ru

S. MARCHENKO

O.M. Filatov City Clinical Hospital Fifteen

Email: info@gkb15.mosgorzdrav.ru

E. KUZINA

Centre of Immunology and Reproduction

Email: kuzina@cironline.ru

Z. TSORAEVA

O.M. Filatov City Clinical Hospital Fifteen

Email: info@gkb15.mosgorzdrav.ru

Bibliografia

  1. Боярский К.Ю., Гайдуков С.Н., Чкуасели А.С. Факторы, определяющие овариальный резерв женщины (обзор литературы). Журнал акушерства и женских болезней. 2009; 58(2): 65—71.
  2. Назаренко Т.А. Стимуляция функции яичников. 3е изд. М.: МЕДпресс-информ; 2011. 272 с.
  3. Al-Azemi M., Killick S.R., Duffy S., Pye C., Refaat B., Hill N., Ledger W Multi-marker assessment of ovarian reserve predicts oocyte yield after ovulation induction. Hum. Reprod. 2011; 26(2): 414—22.
  4. Alper E., Oktem O., Palaoglu E., Peker K., Yakin K., Urman B. The impact of laparoscopic ovarian cystectomy on ovarian reserve as assessed by antral follicle count and serum AMH levels. Fertil. Steril. 2009; 92(Suppl.3): S59.
  5. Al-Sultan H., Kady F. O36 Prospective 3-step treatment of endometriotic ovarian cysts. Int. J. Gynecol. Obstet. 2009; 107(Suppl. 2): S103.
  6. Chang H.J., Han S.H., Lee J.R., Jee B. C., Lee B.I., Suh C.S., Kim S.H. Impact of laparoscopic cystectomy on ovarian reserve: serial changes of serum anti-Mullerian hormone levels. Fertil. Steril. 2010; 94(1): 343—9.
  7. Coccia M.E., Rizzello F. Ovarian reserve. Ann. N. Y. Acad. Sci. 2008; 1127: 27—30.
  8. Donnez J., Squifflet J., Donnez O. Minimally invasive gynecologic procedures. Curr. Opin. Obstet. Gynecol. 2011; 23(4): 289—95.
  9. Ercan C.M., Sakinci M., Duru N.K., Alanbay L., Karasahin K.E., Baser I. Antimullerian hormone levels after laparoscopic endometrioma stripping surgery. Gynecol. Endocrinol. 2010; 26(6): 468—72.
  10. Ficicioglu C., Kutlu T., Baglam E., Bakacak Z. Early follicular antimüllerian hormone as an indicator of ovarian reserve. Fertil. Steril. 2006; 85(3): 592—6.
  11. Hirokawa W., Lwase A., Goto M., Takikawa S., Nagatomo Y., Nakahara T. et al. The post-operative decline in serum anti-Mullerian hormone correlates with the bilaterality and severity of endometriosis. Hum. Reprod. 2011; 26(4): 904—10.
  12. Lwase A., Hirokawa W., Lwase A., Goto M., Takikawa S., Nagatomo Y. et al. Serum anti-Müllerian hormone level is a useful marker for evaluating the impact of laparoscopic cystectomy on ovarian reserve. Fertil. Steril. 2010; 94(7): 2846—9.
  13. La Marca A., Broekmans F.J., Volpe A., Fauser B.C., Macklon N.S. Anti-Mullerian hormone (AMH): what do we still need to know? Hum. Reprod. 2009; 24: 2264—75.
  14. La Marca A., Papaleo E., Grisendi V., Argento C., Giulini S., Volpe A. Development of a nomogram based on markers of ovarian reserve for the individualisation of the follicle-stimulating hormone starting dose in in vitro fertilisation cycles. Br. J. Obstet. Gynaecol. 2012; 119(10): 1171—9.
  15. La Marca A., Sighinolfi G., Radi D., Argento C., Baraldi E., Artenisio A.C. et al. Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). Hum. Reprod. Update. 2010; 16(2): 113—30.
  16. Mohamed M.L., Nouh A.A., El-Behery M.M., Mansour S.A. Effect on ovarian reeerve of lapaeoscopic bipolar elrctrocoagulation versus laparotomic hemostatic sutures during unilateral ovarian cystectomy. Int. J. Gynaecol. Obstet. 2011; 114(1): 69—72.
  17. Nezhat C., Nezhat C., Nezhat F. Ovarian cystectomy. In: Nezhat C., Nezhat C., Nezhat F., eds. Nezhat’s operative gynecologic laparoscopy and hysteroscopy. 3rd ed. Cambridge: Cambridge University Press; 2008: 187—98.
  18. Ruiz-Flores F.J., Garcia-Velasco J.A. Is there a benefit for surgery in endometrioma-associated infertility? Curr. Opin. Obstet. Gynaecol. 2012; 24 (3): 136—40.
  19. Sills E.S., Shurpyak S.A., Gorman D.J., Shkrobot L.V., Murray G.U., O’Connor B.M.G. et al. Fertility patients and their prescriptions: a two-year audit of patient-pharmacist interactions in a reproductive endocrinology practice. Int. Arch. Med. 2009; 2(1): 24.
  20. Visser J.A., de Jong F.H., Laven J.S., Themmen A.P. Anti-Mullerian hormone: a new marker for ovarian function. Reproduction. 2006; 131: 1—9.
  21. Wang J.G., Nakhuda G.S., Guarnaccia M.M., Sauer M.V., Lobo R.A. Müllerian inhibiting substance and disrupted folliculogenesis in polycystic ovary syndrome. Am. J. Obstet. Gynecol. 2007; 196(1): 77.

Arquivos suplementares

Arquivos suplementares
Ação
1. JATS XML
Baixar

Declaração de direitos autorais © Bionika Media, 2013

Este site utiliza cookies

Ao continuar usando nosso site, você concorda com o procedimento de cookies que mantêm o site funcionando normalmente.

Informação sobre cookies